Tempest Announces First Patient Dosed in Randomized Study Evaluating TPST-1120 in First-Line Regimen for Hepatocellular Carcinoma in Clinical Collaboration with Roche

NEXT STORY
This Magic Mushroom Day, Communities Across the Globe Celebrate the Transformative Healing Power of Using Psychedelics as Medicine
PREV STORY
OSE Immunotherapeutics Presented Positive Final Results of Tedopi® Phase 3 Clinical Trial in Secondary Resistant Non-Small Cell Lung Cancer Patients at the European Society for Medical Oncology (ESMO) Virtual Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

HTG Molecular Diagnostics Reports First Quarter 2018 Results

Revenue increased 203% compared to the three-month period in the prior year      ...

author_avatar
NASDAQ Market News

Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol

author_avatar
NASDAQ Market News

ContraFect to Present at the 2019 Janney Healthcare Conference

author_avatar
NASDAQ Market News